Type 2 diabetes mellitus outcomes after laparoscopic gastric bypass in patients with BMI <35 kg/m2 using strict remission criteria: early outcomes of a prospective study among Mexicans
Mild obesity (BMI 30–34.9 kg/m2) is highly prevalent worldwide and is associated with type 2 diabetes mellitus. The efficacy of bariatric surgery remains unclear, including among Mexicans. The criteria for diabetes remission are inconsistent, as they are based on different thresholds for glycated hemoglobin, with remission rates ranging from 43 to 73%.
Mildly obese patients with type 2 diabetes mellitus who underwent laparoscopic gastric bypass were prospectively analyzed. The primary objective was to determine the impact of surgery on their metabolic profiles. Demographic, clinical, and biochemical parameters were measured at baseline and at 3, 6, 9, 12, and 18 months. Diabetes remission rate was defined as an HbA1c <5.7%. Complications within 30 days and weight loss (% total weight loss) were also analyzed.
Twenty-three Mexican patients underwent surgery. Of the 19 patients, evaluable at 18 months, nine (47.4%) achieved complete diabetes remission, seven (36.8%) showed partial remission, and three (15.8%) showed improvement. Significant improvements in lipid profile, cardiovascular risk, blood pressure, and every metabolic parameter were observed, beginning at the first month and throughout the study. The final total percentage weight loss was 24.9%. Three patients (13%) experienced complications, but none required reoperation or died.
Laparoscopic gastric bypass is a safe and effective method to improve the metabolic profile of mildly obese Mexican patients with type 2 diabetes mellitus, inducing high remission rates even when the strictest model is used.
KeywordsBariatric surgery Metabolic surgery Diabetes surgery Diabetes remission Obesity grade 1 Mild obesity Laparoscopic gastric bypass Surgery Mexicans Latinos
Compliance with ethical standards
Conflict of interest
Omar Espinosa, Omar Pineda, Hernan G. Maydón, Elisa M. Sepúlveda, Lizbeth Guilbert, Mónica Amado, and Carlos Zerrweck declare that they have no conflicts of interest or financial ties to disclose.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institution and/or national research committee and with 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in this study.
- 6.American Diabetes A (2012) Standards of medical care in diabetes-2012. Diabetes Care 35(Suppl 1):S11–63Google Scholar
- 8.de la Cruz-Munoz N, Messiah SE, Arheart KL, Lopez-Mitnik G, Lipshultz SE, Livingstone A (2011) Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. J Am Coll Surg 212:505–511 discussion 512-503 CrossRefPubMedGoogle Scholar
- 9.(2015) Standards of medical care in diabetes-2015: summary of revisions. Diabetes Care 38 Suppl:S4Google Scholar
- 11.Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, Bantle JP, Sledge I (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122(248–256):e245Google Scholar
- 12.Buchwald H, Varco E (1978) Metabolic surgery. Grune and Stratton, New YorkGoogle Scholar
- 15.Muller-Stich BP, Senft JD, Warschkow R, Kenngott HG, Billeter AT, Vit G, Helfert S, Diener MK, Fischer L, Buchler MW, Nawroth PP (2015) Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg 261:421–429CrossRefPubMedGoogle Scholar
- 18.Lanzarini E, Csendes A, Gutierrez L, Cuevas P, Lembach H, Molina JC, Musleh M, Braghetto I, Papapietro K, Araya V, Lahsen R, Olguin P, Riffo A, Diaz E, Montt D, Marin L (2013) Type 2 diabetes mellitus in patients with mild obesity: preliminary results of surgical treatment. Obes Surg 23:234–240CrossRefPubMedGoogle Scholar
- 26.Cheng YJ, Gregg EW, Geiss LS, Imperatore G, Williams DE, Zhang X, Albright AL, Cowie CC, Klein R, Saaddine JB (2009) Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: implications for diabetes diagnostic thresholds. Diabetes Care 32:2027–2032CrossRefPubMedPubMedCentralGoogle Scholar